Cantor Fitzgerald adjusted its price target for Teradyne stock (NASDAQ:TER), bringing it down to $150 from the previous $160, while still maintaining an Overweight rating on the company's shares.
In a report released yesterday, C J Muse from Cantor Fitzgerald maintained a Hold rating on KLA (KLAC – Research Report), with a price target ...
Cantor Fitzgerald analyst Sarah James maintained a Buy rating on Cigna (CI – Research Report) yesterday and set a price target of $350.00. The ...
Metsera, Inc. (Nasdaq: MTSR) ("Metsera"), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone ...
NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: MTSR) (“Metsera”), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone (NuSH) analog ...
Floor signage for the offices of DeepSeek (C) is seen in Beijing on January 28, 2025. Fears of upheaval in the AI gold rush rocked Wall Street, following the emergence of a popular ChatGPT-like model ...
Hosted on MSN3d
Cantor Fitzgerald Upgrades Beam Therapeutics (BEAM)Fintel reports that on January 29, 2025, Cantor Fitzgerald upgraded their outlook for Beam Therapeutics (NasdaqGS:BEAM) from Neutral to Overweight. Analyst Price Forecast Suggests 87.91% Upside As of ...
Miami International Holdings, Inc. (MIH), a technology-driven leader in building and operating regulated financial markets ...
Fintel reports that on January 16, 2025, Cantor Fitzgerald initiated coverage of ... options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our ...
Fintel reports that on January 16, 2025, Cantor Fitzgerald initiated coverage of ... options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback